Trial intelligence / Profile preview

PerMIT: Pharmacogenetic Guided Warfarin Therapy

NCT00993200Phase 4Completed

Start
Aug 2009
Primary completion
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of warfarin in thrombosis. Started Aug 2009; status: completed.

02

Drugs

warfarin
03

Conditions

thrombosis

Beyond the preview

Go deeper on NCT00993200.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00993200.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call